Is hyperprogressive disease a specific phenomenom of immunotherapy?

Hyperprogressive disease (HPD) is a novel pattern of response during immunotherapy treatment. Several retrospective studies have evaluated its prevalence among various cancer types and, in particular, in non-small cell lung cancer patients, based on different definition criteria. If HPD is a just a...

Descripción completa

Detalles Bibliográficos
Autores principales: Brambilla, Marta, Russo, Giuseppe Lo, Ferrara, Roberto, Manglaviti, Sara, Garassino, Marina Chiara, Occhipinti, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Open Exploration 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402399/
https://www.ncbi.nlm.nih.gov/pubmed/36046388
http://dx.doi.org/10.37349/etat.2020.00027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402399/
https://www.ncbi.nlm.nih.gov/pubmed/36046388
http://dx.doi.org/10.37349/etat.2020.00027

Ejemplares similares